NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 43598-0436-11 — NITROGLYCERIN 0.4 MG SUBLINGUAL TABLETAI (496 hospitals, 27,132–27,825 samples)
• NDC 00998-0016-15 — PROPARACAINE 0.5 % EYE DROPSAI (294 hospitals, 26,740–27,820 samples)
• NDC 55111-0127-01 — CIPROFLOXACIN 500 MG TABLETAI (151 hospitals, 27,315–27,819 samples)
• NDC 25021-0101-10 — Cefazolin 1 gram injectionAI (437 hospitals, 22,715–27,818 samples)
• NDC 00378-3349-99 — Estradiol 0.025 mg/24hr transdermal patchAI (219 hospitals, 26,867–27,812 samples)
• NDC 60505-3110-00 — Olanzapine 2.5 mg tabletAI (702 hospitals, 27,151–27,808 samples)
• NDC 68084-0045-01 — Paroxetine 20 mg tablets, 100-count blister packAI (638 hospitals, 27,130–27,805 samples)
• NDC 00548-9021-00 — Ketorolac injection 30 mgAI (50 hospitals, 27,333–27,801 samples)
• NDC 60432-0150-16 — Hydroxyzine liquid medicine, 10 mg per 5 mL, 473 mL bottleAI (337 hospitals, 27,313–27,799 samples)
• NDC 70069-0011-01 — Glycopyrrolate injection, 0.2 mg/mL solutionAI (217 hospitals, 26,403–27,798 samples)
• NDC 00121-0675-16 — Valproic acid oral solutionAI (203 hospitals, 27,312–27,789 samples)
• NDC 52268-0302-01 — Polyethylene glycol electrolyte solution oralAI (109 hospitals, 27,312–27,789 samples)
• NDC 50268-0287-13 — Duloxetine 30 mg delayed-release capsuleAI (142 hospitals, 27,312–27,789 samples)
• NDC 00074-4378-24 — Cisatracurium injection, 2 mg/mL, 5 mL vialAI (39 hospitals, 27,748–27,784 samples)
• NDC 00074-4380-79 — Cisatracurium besylate injection, 20 mg/10 mL vialAI (38 hospitals, 27,748–27,784 samples)
• NDC 63323-0462-38 — Sensorcaine with epinephrine local anesthetic injectionAI (77 hospitals, 27,748–27,784 samples)
• NDC 70860-0605-02 — Dexmedetomidine injectable liquid, given in the noseAI (78 hospitals, 27,748–27,784 samples)
• NDC 00409-3382-25 — Sufentanil injection (IV)AI (51 hospitals, 27,748–27,784 samples)
• NDC 00409-4928-11 — Calcium chloride injection syringeAI (183 hospitals, 27,748–27,784 samples)
• NDC 00641-6018-06 — Doxapram injection (intravenous)AI (88 hospitals, 27,748–27,784 samples)
• NDC 25021-0659-05 — Atracurium 10 mg/mL solution, 5 mL vialAI (152 hospitals, 27,748–27,784 samples)
• NDC 63323-0367-41 — Polymyxin B sulfate injection, 500,000-unit vialAI (22 hospitals, 27,748–27,784 samples)
• NDC 60687-0349-01 — Quetiapine 100 mg tablets, 100-count blister packAI (438 hospitals, 27,012–27,777 samples)
• NDC 00904-7077-61 — Venlafaxine extended-release 75 mg capsulesAI (240 hospitals, 27,255–27,777 samples)
• NDC 67877-0419-84 — Linezolid 600 mg tablets, 30-count blister packAI (566 hospitals, 27,125–27,755 samples)
• NDC 00409-1582-29 — Bupivacaine 0.75% numbing injection solutionAI (135 hospitals, 26,193–27,741 samples)
• NDC 71351-0022-10 — Spinal bupivacaine with dextrose injectionAI (249 hospitals, 26,325–27,729 samples)
• NDC 00093-1177-01 — Neomycin sulfate 500 mg tabletsAI (846 hospitals, 27,100–27,721 samples)
• NDC 64253-0222-35 — Heparin lock flush solutionAI (635 hospitals, 22,212–27,720 samples)
• NDC 00338-1125-04 — Amino acid, dextrose and electrolyte IV solutionAI (309 hospitals, 26,257–27,715 samples)
• NDC 00517-2102-01 — Potassium phosphate intravenous solutionAI (111 hospitals, 26,809–27,709 samples)
• NDC 00409-3182-02 — Lidocaine with epinephrine injection solutionAI (341 hospitals, 26,214–27,708 samples)
• NDC 00904-6238-61 — Carbidopa and levodopa tablets 25-250 mgAI (392 hospitals, 27,120–27,705 samples)
• NDC 00245-5319-11 — Potassium chloride extended-release 20 mEq tabletAI (290 hospitals, 27,120–27,705 samples)
• NDC 00832-5325-11 — Potassium chloride extended-release 20 mEq tabletAI (275 hospitals, 27,120–27,705 samples)
• NDC 63739-0572-10 — SIMVASTATIN 20 MG TABLETAI (357 hospitals, 26,972–27,701 samples)
• NDC 63323-0544-01 — Heparin lock flush solutionAI (185 hospitals, 26,859–27,696 samples)
• NDC 00115-1660-01 — propranolol 20 mg tabletAI (183 hospitals, 27,111–27,687 samples)
• NDC 68084-0447-01 — Hydralazine 10 mg tablets, 100-count blister packAI (391 hospitals, 27,118–27,685 samples)
• NDC 00338-1099-04 — Amino acid and dextrose intravenous solutionAI (343 hospitals, 27,070–27,682 samples)
• NDC 68084-0346-01 — Losartan 25 mg tablets, 100-count blister packAI (642 hospitals, 26,826–27,681 samples)
• NDC 70069-0747-01 — Potassium phosphate IV solutionAI (254 hospitals, 26,670–27,678 samples)
• NDC 50268-0278-15 — DOXYCYCLINE HYCLATE 100 MG CAPSULEAI (228 hospitals, 27,117–27,675 samples)
• NDC 60687-0156-25 — Phenytoin chewable tablet 50 mgAI (461 hospitals, 27,188–27,674 samples)
• NDC 69452-0207-20 — Calcitriol 0.25 mcg oral capsulesAI (254 hospitals, 27,116–27,665 samples)
• NDC 68382-0798-01 — labetalol 100 mg tabletAI (387 hospitals, 26,996–27,644 samples)
• NDC 49702-0228-13 — Dolutegravir 50 mg tablets, bottle of 30AI (1060 hospitals, 26,823–27,642 samples)
• NDC 72611-0734-01 — Labetalol 5 mg/mL intravenous syringeAI (304 hospitals, 25,526–27,641 samples)
• NDC 68084-0220-11 — Ondansetron 4 mg oral tabletsAI (252 hospitals, 23,371–27,637 samples)
• NDC 00409-4887-99 — Sterile water for injectionAI (349 hospitals, 27,390–27,633 samples)